Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Country/Region
  • No block ID is set

  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
  • Part of brands: |
InternationalInternational
  • Country/Region
  • Part of brands: |
  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
Our Services > Oncodona

Oncodona

A complete test of genetic screening that analyzes 21 genes related to breast and ovarian cancer.

  • Overview
  • Features
  • How does it Work?
  • I’m a health specialist
igenomix

Early identification of predisposition to inherited cancer.

SAT Sperm aneuploidy test

Results in 30 days.

SAT Sperm aneuploidy test

Harmful mutations can be transmitted with a 50% probability.

Overview

What is Oncodona test?

  • Oncodona is the most advanced genetic test for early identification of predisposition to inherited cancer.
  • This test analyzes 21 genes related to breast and ovarian cancer in order to locate mutations that increase the risk of developing these types of cancer.
  • Oncodona uses Next Generation Sequencing (NGS) to analyze genetic information present in a panel of 21 genes, including BRCA1 and BRCA2 genes, in order to locate harmful mutations.
Features
  • Indications
  • Benefits

Is Oncodona for you?

This test is recommended if:

  • You’ve been diagnosed with breast cancer and BRCA1 and BRCA2 negative genetic test. Oncodona can find a mutation in up to 4% of women.
  • A woman in your family has been diagnosed with breast and ovarian cancer. 
  • You just want to know if you have any risk of developing breast and ovarian cancer.

Why use Oncodona?

  • The performance of the test, if positive, can be used to adopt follow-up and personalized early detection measures of the patient and their relatives.
  • A negative result means that the patient does not have an increased risk. In other words, their risk of suffering one of the types of cancer analysed by the test is the baseline risk of the population.
How does it work?

BROCHURE

Download

Do you have any questions?

supportspain@igenomix.com

Other services you may be interested in

CGT

CGT Carrier Genetic Test

Genetic disorders can’t be cured, but they can be prevented.

CGT is an important genetic test when planning a family, because it helps to determine the risk of having a child with a genetic disease.

More information

PGT-M

PGT-M Preimplantation Genetic Testing

(Preimplantation Genetic Testing for Monogenic disorders)

PGT-M helps couples with a risk of transmitting a genetic disease. This genetic test Prevents the transmission of inherited disorders to future children and achieve a healthy pregnancy.

More information

PGT-A

PGT-A Preimplantation Genetic Testing

(Preimplantation Genetic Testing for Aneuploidies)

Is a genetic test performed embryos obtained with IVF thathelps you to have a successful pregnancy and a healthy baby. PGT-A increases the chances of an ongoing healthy and pregnancy.

More information

Igenomix is in the media

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic testing solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us
Terms and conditions

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Country/Region

[2024] © Igenomix Privacy Page Quality policy Legal note Cookies policy

Request Information


  • Patient Journey
    • Before Pregnancy
    • IVF Process
    • Healthy pregnancy
    • After birth
  • Reproductive Health
    • Specialists
      • ERA
      • ERA insight Hub
      • ALICE
      • EMMA
      • EndomeTRIO
      • Infertility Panels
      • EMBRACE
      • PGT-A
      • PGT-A Plus
      • PGT-M
      • PGT-SR
      • CGT
      • NACE
      • Zenit
      • POC Portfolio
      • SAT
      • Newborn Screening
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
    • Igenomix Worldwide
  • Academy
  • Blog
  • Country/Region
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information